JP2025023868A - Nod様受容体タンパク質3の阻害剤として有用なフタラジン誘導体 - Google Patents
Nod様受容体タンパク質3の阻害剤として有用なフタラジン誘導体 Download PDFInfo
- Publication number
- JP2025023868A JP2025023868A JP2024174701A JP2024174701A JP2025023868A JP 2025023868 A JP2025023868 A JP 2025023868A JP 2024174701 A JP2024174701 A JP 2024174701A JP 2024174701 A JP2024174701 A JP 2024174701A JP 2025023868 A JP2025023868 A JP 2025023868A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- trifluoromethyl
- pyridazin
- pyrido
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263409432P | 2022-09-23 | 2022-09-23 | |
| US63/409,432 | 2022-09-23 | ||
| JP2024543314A JP7707451B2 (ja) | 2022-09-23 | 2023-09-21 | Nod様受容体タンパク質3の阻害剤として有用なフタラジン誘導体 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024543314A Division JP7707451B2 (ja) | 2022-09-23 | 2023-09-21 | Nod様受容体タンパク質3の阻害剤として有用なフタラジン誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025023868A true JP2025023868A (ja) | 2025-02-17 |
| JP2025023868A5 JP2025023868A5 (https=) | 2025-05-19 |
Family
ID=94633251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024174701A Pending JP2025023868A (ja) | 2022-09-23 | 2024-10-04 | Nod様受容体タンパク質3の阻害剤として有用なフタラジン誘導体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2025023868A (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025512651A (ja) * | 2022-09-23 | 2025-04-22 | メルク・シャープ・アンド・ドーム・エルエルシー | Nod様受容体タンパク質3の阻害剤として有用なフタラジン誘導体 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016520115A (ja) * | 2013-05-28 | 2016-07-11 | レデックス ファーマ ピーエルシーRedx Pharma Plc | ヘッジホッグシグナル伝達経路阻害剤としての複素環化合物 |
| WO2022135567A1 (zh) * | 2020-12-25 | 2022-06-30 | 上海拓界生物医药科技有限公司 | 一类含哒嗪的化合物及其医药用途 |
| WO2022166890A1 (zh) * | 2021-02-08 | 2022-08-11 | 南京明德新药研发有限公司 | 取代的哒嗪苯酚类衍生物 |
| WO2022216971A1 (en) * | 2021-04-07 | 2022-10-13 | Ventus Therapeutics U.S., Inc. | Pyridazine compounds for inhibiting nlrp3 |
| WO2023028534A1 (en) * | 2021-08-25 | 2023-03-02 | Ptc Therapeutics, Inc. | Inhibitors of nlrp3 |
-
2024
- 2024-10-04 JP JP2024174701A patent/JP2025023868A/ja active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016520115A (ja) * | 2013-05-28 | 2016-07-11 | レデックス ファーマ ピーエルシーRedx Pharma Plc | ヘッジホッグシグナル伝達経路阻害剤としての複素環化合物 |
| WO2022135567A1 (zh) * | 2020-12-25 | 2022-06-30 | 上海拓界生物医药科技有限公司 | 一类含哒嗪的化合物及其医药用途 |
| WO2022166890A1 (zh) * | 2021-02-08 | 2022-08-11 | 南京明德新药研发有限公司 | 取代的哒嗪苯酚类衍生物 |
| WO2022216971A1 (en) * | 2021-04-07 | 2022-10-13 | Ventus Therapeutics U.S., Inc. | Pyridazine compounds for inhibiting nlrp3 |
| WO2023028534A1 (en) * | 2021-08-25 | 2023-03-02 | Ptc Therapeutics, Inc. | Inhibitors of nlrp3 |
Non-Patent Citations (1)
| Title |
|---|
| NORBERT HAIDER ET AL.: "Pyridazin-Analoga biologisch aktiver Verbindungen, 2 Mitt. 4-Aryl-pyridazino[4,5-d]pyridazine mit cy", ARCH. PHARM. (WEINHEIM), vol. 315, JPN6025044105, 1982, pages 778 - 783, ISSN: 0005718430 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025512651A (ja) * | 2022-09-23 | 2025-04-22 | メルク・シャープ・アンド・ドーム・エルエルシー | Nod様受容体タンパク質3の阻害剤として有用なフタラジン誘導体 |
| JP7707451B2 (ja) | 2022-09-23 | 2025-07-14 | メルク・シャープ・アンド・ドーム・エルエルシー | Nod様受容体タンパク質3の阻害剤として有用なフタラジン誘導体 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7707451B2 (ja) | Nod様受容体タンパク質3の阻害剤として有用なフタラジン誘導体 | |
| JP7575518B2 (ja) | Nav1.8阻害剤としての2-オキソイミダゾリジン-4-カルボキサミド | |
| JP2023530319A (ja) | Nav1.8阻害剤としての2-オキソ-オキサゾリジン-5-カルボキサミド | |
| KR20230026405A (ko) | Nav1.8 억제제로서의 5-옥소피롤리딘-3-카르복스아미드 | |
| KR20240005878A (ko) | Nav1.8 억제제로서의 시클로알킬 3-옥소피페라진 카르복스아미드 및 시클로헤테로알킬 3-옥소피페라진 카르복스아미드 | |
| EP4637746A1 (en) | 6,6 bicyclic heterocyles useful as inhibitors of nod-like receptor protein 3 | |
| WO2022235558A1 (en) | Aryl 3-oxopiperazine carboxamides and heteroaryl 3-oxopiperazine carboxamides as nav1.8 inhibitors | |
| EP4611743A1 (en) | Triazines useful as inhibitors of nod-like receptor protein 3 | |
| KR20170129810A (ko) | 치환된 트리시클릭 헤테로시클릭 화합물 | |
| JP2025023868A (ja) | Nod様受容体タンパク質3の阻害剤として有用なフタラジン誘導体 | |
| JP7815552B1 (ja) | Nod様受容体タンパク質3の阻害薬として有用な5,6-不飽和二環式ヘテロ環 | |
| EP4719386A2 (en) | 5,6 saturated bicyclic heterocyles useful as inhibitors of nod-like receptor protein 3 | |
| KR20230097093A (ko) | Lrrk2 억제제로서의 n-연결된 이소퀴놀린 아미드, 제약 조성물 및 그의 용도 | |
| EA052925B1 (ru) | Производные фталазина, пригодные в качестве ингибиторов белка 3 nod-подобного рецептора | |
| JP2026009108A (ja) | Nod様受容体タンパク質3の阻害薬として有用な5,6-不飽和二環式ヘテロ環 | |
| TW202532066A (zh) | 作為nod樣受體蛋白3抑制劑之氮雜吲唑衍生物 | |
| US20250195511A1 (en) | Indazole derivatives useful as inhibitors of nod-like receptor protein 3 | |
| WO2025032440A1 (en) | Klf2 inducing compounds and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241016 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20241016 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250509 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20251028 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260122 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260414 |